Over the past 12 months, a number of medtech companies at various stages hauled in significant funding rounds to support ...

CMS announced a proposed decision to cover transcatheter tricuspid valve replacement (TTVR) for Medicare beneficiaries.

With approval, the company can begin commercializing the device in the U.S. in 2025.

Roivios announced that it received FDA investigational device exemption (IDE) approval to conduct a trial for its renal ...

Andromeda Surgical announced that a surgeon performed a robotic-assisted holmium laser enucleation of the prostate (HoLEP) ...

Onward Medical announced today that it received FDA de novo clearance for its ARC-EX spinal cord stimulation (SCS) system.

[Image courtesy of Smith+Nephew] Smith+Nephew (NYSE: SNN) + announced today that it received FDA clearance for its Coriograph pre-op planning and modeling services. The London-based orthopedic ...

[Image courtesy of Dexcom/Oura] Oura announced today that it completed a $200 million Series D funding round that included Dexcom (Nasdaq:DXCM). The investment comes as part of a new health ...

Medline announced today that it confidentially submitted a draft registration to the U.S. SEC related to a proposed initial public offering (IPO). The Northfield, Illinois—based company ...